{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:42Z","timestamp":1790094642205,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jbc.2025.108164","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:07:05Z","timestamp":1736359625000},"page":"108164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Discovery of a tribenzophenazine analog for binding to the KRAS mRNA G-quadruplex structures in the cisplatin-resistant non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"301","author":[{"given":"Xiao-Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108164_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.108164_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2025.108164_bib3","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2025.108164_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1242\/jcs.182873","article-title":"RAS isoforms and mutations in cancer at a glance","volume":"129","author":"Hobbs","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbc.2025.108164_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2025.108164_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"Fernandez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jbc.2025.108164_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-022-01629-2","article-title":"Targeting KRAS mutant cancers: from druggable therapy to drug resistance","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.108164_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/emboj.2010.7","article-title":"Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival","volume":"29","author":"Drosten","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.108164_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in RAS-targeted cancer therapies","volume":"19","author":"Punekar","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.108164_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101974","article-title":"KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?","volume":"84","author":"Nagasaka","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.jbc.2025.108164_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRAS(G12C) inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2025.108164_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.108164_bib13","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4161\/cc.8.17.9336","article-title":"Oncogenic K-ras \"addiction\" and synthetic lethality","volume":"8","author":"Singh","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2025.108164_bib14","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2025.108164_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.108164_bib17","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"Burge","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.108164_bib18","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1158\/0008-5472.CAN-06-1581","article-title":"The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in\u00a0vitro and induces GFP-POT1 dissociation from telomeres in human cells","volume":"66","author":"Gomez","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.108164_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12943-022-01649-y","article-title":"Ligands stimulating antitumour immunity as the next G-quadruplex challenge","volume":"21","author":"Miglietta","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.108164_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nchem.1126","article-title":"A\u00a0single-molecule platform for investigation of interactions between G-quadruplexes and small-molecule ligands","volume":"3","author":"Koirala","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib21","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1093\/nar\/gks068","article-title":"5'-UTR RNA G-quadruplexes: translation regulation and targeting","volume":"40","author":"Bugaut","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.108164_bib22","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1021\/jacs.6b04506","article-title":"A\u00a0small molecule that represses translation of G-quadruplex-containing mRNA","volume":"138","author":"Katsuda","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.108164_bib23","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1093\/nar\/gkq563","article-title":"A\u00a0G-quadruplex structure within the 5'-UTR of TRF2 mRNA represses translation in human cells","volume":"38","author":"Gomez","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.108164_bib24","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1074\/jbc.M116.744839","article-title":"Irregular G-quadruplexes found in the untranslated regions of human mRNAs influence translation","volume":"291","author":"Bolduc","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib25","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C1CC15850C","article-title":"Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5'-UTR of KRAS oncogene represses translation","volume":"48","author":"Faudale","year":"2012","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.jbc.2025.108164_bib26","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/acs.jmedchem.7b00622","article-title":"RNA G-quadruplexes in kirsten ras (KRAS) oncogene as targets for small molecules inhibiting translation","volume":"60","author":"Miglietta","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib27","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1093\/nar\/gkz835","article-title":"New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription","volume":"47","author":"Hu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.108164_bib28","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1021\/acs.jmedchem.0c02202","article-title":"New dibenzoquinoxalines inhibit triple-negative breast cancer growth by dual targeting of topoisomerase 1 and the c-MYC G-quadruplex","volume":"64","author":"Hu","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2023.111549","article-title":"Development of a high-contrast fluorescent ligand that targets G-quadruplexes by introducing a triazole rotor onto the dibenzoquinoxaline scaffold","volume":"219","author":"Nie","year":"2023","journal-title":"Dyes Pigm."},{"key":"10.1016\/j.jbc.2025.108164_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116536","article-title":"Novel quinoxaline analogs as telomeric G-quadruplex ligands exert antitumor effects related to enhanced immunomodulation","volume":"274","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib31","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acsptsci.4c00234","article-title":"Promising G-quadruplex-targeted dibenzoquinoxaline type-1 photosensitizer triggers DNA damage in triple-negative breast cancer cells","volume":"7","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jbc.2025.108164_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-023-03973-3","article-title":"HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2\/miR-130a-3p-dependent mechanism","volume":"21","author":"Cui","year":"2023","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.jbc.2025.108164_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio864","article-title":"An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation","volume":"3","author":"Kumari","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2025.108164_bib34","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1021\/jacs.8b09329","article-title":"Identification of G-quadruplex-binding protein from the exploration of RGG motif\/G-quadruplex interactions","volume":"140","author":"Huang","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.108164_bib35","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/jacs.0c10792","article-title":"Photoactive G-quadruplex ligand identifies multiple G-quadruplex-related proteins with extensive sequence tolerance in the cellular environment","volume":"143","author":"Su","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.108164_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-59745-363-9_5","article-title":"Biochemical techniques for the characterization of G-quadruplex structures: EMSA, DMS footprinting, and DNA polymerase stop assay","volume":"608","author":"Sun","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2025.108164_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchem.1548","article-title":"Quantitative visualization of DNA G-quadruplex structures in human cells","volume":"5","author":"Biffi","year":"2013","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2018.07.013","article-title":"KRAS-Mutant non-small cell lung cancer: from biology to therapy","volume":"124","author":"Ferrer","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jbc.2025.108164_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","article-title":"MEK inhibitors for the treatment of non-small cell lung cancer","volume":"14","author":"Han","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jbc.2025.108164_bib40","article-title":"Discovery of small molecule NSC290956 as a therapeutic agent for KRas mutant non-small-cell lung cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108164_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2184.2011.00753.x","article-title":"Cdc2: a monopotent or pluripotent CDK?","volume":"44","author":"Hu","year":"2011","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jbc.2025.108164_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.108164_bib43","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.108164_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","article-title":"BCL-2 proteins and apoptosis: recent insights and unknowns","volume":"500","author":"Edlich","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.108164_bib45","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/acs.jmedchem.2c00880","article-title":"A\u00a0photoactivated sorafenib-ruthenium(II) prodrug for resistant hepatocellular carcinoma therapy through ferroptosis and purine metabolism disruption","volume":"65","author":"Lai","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2025.108164_bib46","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/acs.jmedchem.1c01301","article-title":"One-pot enzymatic synthesis and biological evaluation of ganglioside GM3 derivatives as potential cancer immunotherapeutics","volume":"65","author":"Wang","year":"2022","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T15:08:47Z","timestamp":1740496127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0021925825000110"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108164","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a tribenzophenazine analog for binding to the KRAS mRNA G-quadruplex structures in the cisplatin-resistant non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108164"}}